Rehmann Capital Advisory Group’s Dynavax Technologies DVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding DVAX
DTC
TCM
CC
DM
Rehmann Capital Advisory Group's DVAX Position: Q1 2025 in Review
Rehmann Capital Advisory Group sold out of Dynavax Technologies (DVAX) in Q1 2025, closing a stake of 24,020 shares — an estimated $307K sold.
Rehmann Capital Advisory Group first reported a position in DVAX in Q2 2024 and held it in 3 quarters. The position peaked at $307K in Q4 2024. 284 funds tracked by Wall St. Rank hold DVAX as of Q1 2025.
- Rehmann Capital Advisory Group reported no remaining Dynavax Technologies position as of Q1 2025 after selling out during the quarter.
- Rehmann Capital Advisory Group sold 24,020 Dynavax Technologies shares in Q1 2025, an estimated $307K.
- Rehmann Capital Advisory Group first reported a position in Dynavax Technologies in Q2 2024 and held it in 3 quarters.
- Rehmann Capital Advisory Group's Dynavax Technologies position peaked at $307K in Q4 2024.
- 284 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2025.
Based on Rehmann Capital Advisory Group's 13F filing for Q1 2025, filed 30 Apr 2025.